Logo

NorayBio Licenses Noraynet to BioDynamics

Jul 20, 2006
NEW YORK (GenomeWeb News) - NorayBio licensed its biopharmaceutical platform to BioDynamics, NorayBio said today.
 
The platform, Noraymet ADME, predicts human pharmacokinetic models of new compounds from in vitro ADME data.
 
NorayBio has licensed the product to Spain's Faes Farma and Finland's Novamass.
 
NorayBio and BioDynamics also plan to co-develop software based on Noraymet ADME to refine human pharmacokinetic modelling.

Filed under

Informatics
Breaking News
The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.